CDLWL - AQUA-KEM TOSS-INS

  • MSDS: CDLWL
  • Manufacturer: THETFORD CORP
  • Product Name: AQUA-KEM TOSS-INS
  • National Stock Number: 6840-01-393-7045
Product Identification

Product ID:AQUA-KEM TOSS-INS
MSDS Date:09/01/1990
FSC:6840
NIIN:01-393-7045
MSDS Number: CDLWL

Responsible Party
THETFORD CORPORATION
7101 JACKSON ROAD
ANN ARBOR, MI 48103
US

Emergency Phone: 313-769-6000/313-769-6003

Info Phone: 313-769-6000/313-769-6003

Cage: DO910

Contractor
THETFORD CORPORATION
ANN ARBOR, MI 48103 US

Telephone: 734-769-6000

Cage: DO910

Ingredients

PARAFORMALDEHYDE

CAS: 30525-89-4

RTECS: RV0540000

EPA Report Quantity: 1000 LBS

DOT Report Quantity: 1000 LBS

Hazards

LD50 LC50 Mixture:PRODUCT'S LD50 (ORAL RAT) WAS NOT STATED
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:YES IARC:YES OSHA:YES
Health Hazards Acute and Chronic:CAN PRODUCE EYE DAMAGE & SKIN
SENSITIZATION. MUTAGENIC ACTIVITY IN BACTERIAL & MAMALIAN CELL
CULTURE TEST SYMPTOMS-BUT NOT MUTAGENIC IN WHOLE ANIMAL SYSTEMS.
NOT TERATOGENIC. HIGH INHALATION EXPOSURE MAY CAUSE
BRONCHOPNEUMONIA & ADEMA.
Explanation of Carcinogenicity:CARCINOGENIC POTENTIAL IS BASED ON
ANIMAL EVIDENCE. HUMAN EVIDENCE SHOWS NO INCREASED RISK OF CANCER.
Effects of Overexposure:INHALATION PRODUCES IRRITATION TO UPPER
RESPIRATORY TRACT & EYE IRRITATION. MAY INCLUDE DISCOMFORT SUCH AS
NAUSEA, HEADACHE OR WEAKNESS. SKIN CONTACT PRODUCES IRRITATION
W/DISCOMFORT OR RASH. EYE CONT ACT CAUSES IRRITATION OR SEVERE
BURNS.
Medical Cond Aggravated by Exposure:PERSONS HAVING PREEXISTING DISEASES
OF THE LUNGS, EYES OR SKIN MAY HAVE INCREASED SUSCEPTABILITY TO THE
HAZARDS OF EXCESSIVE EXPOSURE.

First Aid

First Aid:FLUSH CONTACTED AREA WITH LARGE AMOUNTS OF WATER. IRRIGATE
EYES FOR A MINIMUM OF 15 MIN. IF SWALLOWED, INDUCE VOMITING BY
GIVING 2 GLASSES OF WATER & STICKING FINGER DOWN THE THROAT. FOR
EYE CONTACT O R INGESTION, CALL A PHYSICIAN.

Fire Fighting

Flash Point Method:TCC
Flash Point:140F,60C
Lower Limits:7.00
Upper Limits:73.00
Extinguishing Media:WATER, DRY CHEMICAL, CARBON DIOXIDE OR FOAM.
Fire Fighting Procedures:WEAR SELF-CONTAINED BREATHING APPARATUS
Unusual Fire/Explosion Hazard:NONE

Accidental Release

Spill Release Procedures:VENTILATE AREA BY OPENING DOORS & WINDOWS. USE
FAN IF AVAILABLE. WEAR FORMALDEHYDE RESPIRATOR. SWEEP UP SPILLED
MATERIAL. NEUTRALIZE REMAINING ODOR W/DILUTE AMMONIA SOLUTION. MOP
AREA W/LARGE AMOUNTS OF WATER. WORK FOR SHORT PERIODS OF TIME.
Neutralizing Agent:MFR GAVE NO INFORMATION OF MSDS.

Handling

Handling and Storage Precautions:DO NOT STORE ABOVE 110F. DO NOT GET ON
SKIN OR IN EYES. DO NOT INHALE VAPORS OR DUST.
Other Precautions:DO NOT GET IN EYES OR ON SKIN. DO NOT INHALE VAPORS.
WASH THOROUGHLY AFTER HANDLING.

Exposure Controls

Respiratory Protection:WEAR VAPOR MASK W/AN ORGANIC VAPOR CARTRIDGE OR
FORMALDEHYDE CARTRIDGE FOR SMALL SPILLS, SELF-CONTAINED BREATHING
APPARATUS FOR LARGER SPILLS.
Ventilation:USE LOCAL EXHAUST TO MAINTAIN ADEQUATE VENTILATION.
Protective Gloves:PROTECTIVE GLOVES RECOMMENDED.
Eye Protection:EYE PROTECTION RECOMMENDED.
Other Protective Equipment:PROTECTIVE CLOTHING TO AVOID SKIN CONTACT.
EYE WASH STATION & SAFETY SHOWER.
Work Hygienic Practices:AVOID UNNECESSARY & PROLONGED EXPOSURE. AVOID
BREATHING VAPORS.
Supplemental Safety and Health
ANY TRANSPORTATION QUESTIONS CAN BE ANSWERED BY THETFORD CORPORATION'S
TRAFFIC DEPARTMENT.

Chemical Properties

HCC:N1
NRC/State Lic Num:NONE
Boiling Pt:B.P. Text:N/A.
Melt/Freeze Pt:M.P/F.P Text:248F,120C
Vapor Pres:<2.0
Vapor Density:1.03
Spec Gravity:N/A.
Solubility in Water:90%
Appearance and Odor:BLUE GRANULES WITH PUNGET ODOR. - PH 10% SOLUTION =
9-10

Stability

Stability Indicator/Materials to Avoid:YES
STRONG ALKALIES, INORGANIC ACIDS, ISOCYANATES, ANHYDRIDES, OXIDES.
Stability Condition to Avoid:ELEVATED TEMPERATURES.
Hazardous Decomposition Products:THERMAL DECOMPOSITOIN MAY PRODUCE
CARBON MONOXIDE &/OR CARBON DIOXIDE.
Conditions to Avoid Polymerization:WILL NOT OCCUR.

Disposal

Waste Disposal Methods:INCINERATION OR BIOLOGICAL TREATMENT IN A
FEDERAL/STATE APPROVED TREATMENT FACILITY.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.